BioMall
Brand Store/BDB Bioscience/BD HorizonTM BV786 Mouse Anti-Mouse H-2K[b]/SIINFEKL
BD HorizonTM BV786 Mouse Anti-Mouse H-2K[b]/SIINFEKL
GENERAL CATALOGUE

BD HorizonTM BV786 Mouse Anti-Mouse H-2K[b]/SIINFEKL

570096 · 25 ug

BDB Bioscience · Cat: 570096

₹100 – ₹160 approx.This price excludes freight and taxes. Please RFQ to get the final price.

Reach 3+ verified distributors

Catalog No: 570096
Category: reagents
Pack Size: 25 ug
Brand: BDB Bioscience

Description

Flow cytometric analysis of H-2K b /SIINFEKL expression on viable C57BL/6 Mouse splenic leukocytes with or without prior SIINFEKL peptide treatment. Mouse splenic leukocytes were either not pulsed Left Plot or were pulsed Right Plot with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553142 . The cells were stained with either BD Horizon BV786 Mouse IgG1, kappa Isotype Control Cat. No. 563330; dashed line histograms or with BD Horizon BV786 Mouse Anti-Mouse H-2K b /SIINFEKL antibody Cat. No. 570015/570096; solid line histograms at 0.25 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histogram showing H-2K b /SIINFEKL expression or Ig Isotype control expression was derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative splenic leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific. Multiparameter flow cytometric analysis of H-2K b /SIINFEKL expression on viable C57BL/6 Mouse splenic leukocytes with prior SIINFEKL peptide treatment. Mouse splenic leukocytes were pulsed with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553142 . The cells were stained with either BD Horizon BV786 Mouse IgG1, kappa Isotype Control Cat. No. 563330; Left Plot or BD Horizon BV786 Mouse Anti-Mouse H-2K b /SIINFEKL antibody Cat. No. 570015/570096; Right Plot at 0.25 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of H-2K b /SIINFEKL or Ig Isotype control staining versus side-light scatter SSC-A signals was derived from gated events with the forward and side-light scatter characteristics of viable DAPI-negative splenic leukocyte populations. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific. Flow cytometric analysis of H-2K b /SIINFEKL expression on viable C57BL/6 Mouse splenic leukocytes with or without prior SIINFEKL peptide treatment. Mouse splenic leukocytes were either not pulsed Left Plot or were pulsed Right Plot with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553142 . The cells were stained with either BD Horizon BV786 Mouse IgG1, kappa Isotype Control Cat. No. 563330; dashed line histograms or with BD Horizon BV786 Mouse Anti-Mouse H-2K b /SIINFEKL antibody Cat. No. 570015/570096; solid line histograms at 0.25 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histogram showing H-2K b /SIINFEKL expression or Ig Isotype control expression was derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative splenic leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific. Show More Multiparameter flow cytometric analysis of H-2K b /SIINFEKL expression on viable C57BL/6 Mouse splenic leukocytes with prior SIINFEKL peptide treatment. Mouse splenic leukocytes were pulsed with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553142 . The cells were stained with either BD Horizon BV786 Mouse IgG1, kappa Isotype Control Cat. No. 563330; Left Plot or BD Horizon BV786 Mouse Anti-Mouse H-2K b /SIINFEKL antibody Cat. No. 570015/570096; Right Plot at 0.25 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of H-2K b /SIINFEKL or Ig Isotype control staining versus side-light scatter SSC-A signals was derived from gated events with the forward and side-light scatter characteristics of viable DAPI-negative splenic leukocyte populations. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific. Show More Flow cytometric analysis of H-2K b /SIINFEKL expression on viable C57BL/6 Mouse splenic leukocytes with or without prior SIINFEKL peptide treatment. Mouse splenic leukocytes were either not pulsed Left Plot or were pulsed Right Plot with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553142 . The cells were stained with either BD Horizon BV786 Mouse IgG1, kappa Isotype Control Cat. No. 563330; dashed line histograms or with BD Horizon BV786 Mouse Anti-Mouse H-2K b /SIINFEKL antibody Cat. No. 570015/570096; solid line histograms at 0.25 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histogram showing H-2K b /SIINFEKL expression or Ig Isotype control expression was derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative splenic leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific. Multiparameter flow cytometric analysis of H-2K b /SIINFEKL expression on viable C57BL/6 Mouse splenic leukocytes with prior SIINFEKL peptide treatment. Mouse splenic leukocytes were pulsed with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553142 . The cells were stained with either BD Horizon BV786 Mouse IgG1, kappa Isotype Control Cat. No. 563330; Left Plot or BD Horizon BV786 Mouse Anti-Mouse H-2K b /SIINFEKL antibody Cat. No. 570015/570096; Right Plot at 0.25 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of H-2K b /SIINFEKL or Ig Isotype control staining versus side-light scatter SSC-A signals was derived from gated events with the forward and side-light scatter characteristics of viable DAPI-negative splenic leukocyte populations. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific.

More from BDB Bioscience